Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
6.62
-0.37 (-5.29%)
Mar 31, 2025, 1:43 PM EDT - Market open
Immunome Market Cap
Immunome has a market cap or net worth of $575.61 million as of March 31, 2025. Its market cap has decreased by -56.37% in one year.
Market Cap
575.61M
Enterprise Value
359.66M
1-Year Change
-56.37%
Ranking
Category
Stock Price
$6.62
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $575.61M, an increase of 416.75%. That is a compound annual growth rate of 44.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 607.79M | -8.31% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |